Table 3.
Clinico-pathological variables for the patient cohort (n = 1458).
| Clinico-Pathological Variables | n (%) |
|---|---|
| Age | |
| Median | 38.0 |
| Range (IQR) ^ | 29.0–50.0 |
| <55 years | 1189 (81.5) |
| ≥55 years | 269 (18.5) |
| Gender | |
| Female | 1102 (75.6) |
| Male | 356 (24.4) |
| Histopathology | |
| Classical Variant | 955 (65.5) |
| Follicular Variant | 258 (17.7) |
| Tall Cell Variant | 135 (9.3) |
| Others | 110 (7.5) |
| Extrathyroidal Extension | |
| Absent | 834 (57.2) |
| Present | 624 (42.8) |
| pT | |
| T1 | 400 (27.4) |
| T2 | 298 (20.4) |
| T3 | 595 (40.9) |
| T4 | 110 (7.5) |
| Unknown | 55 (3.8) |
| pN | |
| N0 | 582 (39.9) |
| N1 | 728 (49.9) |
| Nx | 148 (10.2) |
| pM | |
| M0 | 1401 (96.1) |
| M1 | 57 (3.9) |
| Stage | |
| I | 1188 (81.5) |
| II | 152 (10.4) |
| III | 19 (1.3) |
| IVA | 19 (1.3) |
| IVB | 30 (2.1) |
| Unknown | 50 (3.4) |
| BRAF Mutation | |
| Present | 707 (48.5) |
| Absent | 550 (37.7) |
| Unknown | 201 (13.8) |
| RAI Therapy | |
| Yes | 1113 (76.3%) |
| No | 345 (23.7) |
^ IQR—Interquartile range; RAI—Radioactive iodine.